Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Direct comparison of oral Navelbine given classic vs metronomic in metastatic breast cancer
2016-002165-63Phase 2Completed
- Sponsor
- Aarhus University Hospital
- Start
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of vinorelbine in breast cancer (2 arms), sponsored by Aarhus University Hospital. Started Apr 2017; status: completed.
02
Drugs
vinorelbine
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2016-002165-63.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-002165-63.